Stockscreener 앱 받기
2.90
4.32%
0.12
시간 외 거래:
2.90
전일 마감가:
$2.78
열려 있는:
$2.88
하루 거래량:
11,737
Relative Volume:
0.64
시가총액:
$2.28M
수익:
-
순이익/손실:
$-9.29M
주가수익비율:
-0.5577
EPS:
-5.2
순현금흐름:
$-9.42M
1주 성능:
+18.85%
1개월 성능:
+14.62%
6개월 성능:
-18.54%
1년 성능:
-37.78%
1일 변동 폭
$2.67
$2.90
1주일 범위
$2.23
$2.90
52주 변동 폭
$1.90
$8.92
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
명칭
Scinai Immunotherapeutics Ltd Adr
전화
972-8-9302529
주소
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
SCNI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
2.90 | 2.28M | 0 | -9.29M | -9.42M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Scinai Immunotherapeutics Ltd Adr 주식(SCNI)의 최신 뉴스
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters $10M Standby Equity Purchase Agreement - Barchart
Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Evaluating the Annual Growth - The News Heater
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart
Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Scinai Immunotherapeutics Ltd Adr (SCNI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):